SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-19-014409
Filing Date
2019-03-18
Accepted
2019-03-15 18:56:28
Documents
54
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tv515276_10k.htm 10-K 778012
2 EXHIBIT 10.31 tv515276_ex10-31.htm EX-10.31 236424
3 EXHIBIT 23.1 tv515276_ex23-1.htm EX-23.1 4256
4 EXHIBIT 31.1 tv515276_ex31-1.htm EX-31.1 8387
5 EXHIBIT 31.2 tv515276_ex31-2.htm EX-31.2 8236
6 EXHIBIT 32.1 tv515276_ex32-1.htm EX-32.1 4091
7 EXHIBIT 32.2 tv515276_ex32-2.htm EX-32.2 4068
  Complete submission text file 0001144204-19-014409.txt   5667427

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cik0001651407-20181231.xml EX-101.INS 1540939
9 XBRL TAXONOMY EXTENSION SCHEMA cik0001651407-20181231.xsd EX-101.SCH 36934
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cik0001651407-20181231_cal.xml EX-101.CAL 28993
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cik0001651407-20181231_def.xml EX-101.DEF 233545
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE cik0001651407-20181231_lab.xml EX-101.LAB 257061
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cik0001651407-20181231_pre.xml EX-101.PRE 268894
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38128 | Film No.: 19686373
SIC: 2834 Pharmaceutical Preparations